Key facts
- Notable investors include Biospring Partners.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Cedar Health Research
- ·The full record, as it builds
Funding rounds
No funding rounds for Cedar Health Research are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cedar Health Research
Operator of a multi-specialty clinical research site intended to transform the clinical research domain through the effective adoption of innovative technologies in a research site network that produces data with integrity. The company offers trial criteria analysis, feasibility results, and patient match findings, enabling sponsors, CROs, and physicians to recruit and monitor patient outcomes offering patients additional options for managing their condition while maintaining seamless and safe coordination of care.
- Sector
- Healthcare
- HQ
- Dallas, TX, United States
- Founded
- 2019
- Employees
- 43
- Website
- cedarhealthresearch.com/
- Ownership
- Privately Held (backing)
Cedar Health Research doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cedar Health Research shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cedar Health Research in its N-PORT filings yet. We sweep new filings monthly.